Published in J Musculoskelet Neuronal Interact on December 01, 2013
Urinary Tract Stones and Osteoporosis: Findings From the Women's Health Initiative. J Bone Miner Res (2015) 0.81
Associations of Protein Intake and Protein Source with Bone Mineral Density and Fracture Risk: A Population-Based Cohort Study. J Nutr Health Aging (2015) 0.78
Changing patterns of prescription in vitamin D supplementation in adults: analysis of a regional dataset. Osteoporos Int (2015) 0.76
Self-Report Dietary Assessment Tools Used in Canadian Research: A Scoping Review. Adv Nutr (2017) 0.75
Association between the awareness of osteoporosis and the quality of care for bone health among Korean women with osteoporosis. BMC Musculoskelet Disord (2014) 0.75
Vitamin D deficiency. N Engl J Med (2007) 59.34
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09
Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA (2010) 11.59
Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ (2010) 10.85
A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med (2012) 6.85
Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. Osteoporos Int (2012) 4.09
Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr (2010) 3.86
Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) (2007) 3.51
Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res (1994) 3.29
A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab (2001) 3.16
Effect of annual intramuscular vitamin D on fracture risk in elderly men and women--a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology (Oxford) (2007) 2.81
Vitamin D for cancer prevention: global perspective. Ann Epidemiol (2009) 2.61
Standardization of bone mineral density at femoral neck, trochanter and Ward's triangle. Osteoporos Int (2001) 2.25
Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab (2007) 2.11
The vitamin D epidemic and its health consequences. J Nutr (2005) 2.04
The vitamin D status of Canadians relative to the 2011 Dietary Reference Intakes: an examination in children and adults with and without supplement use. Am J Clin Nutr (2011) 1.87
Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol (2008) 1.85
Universal standardization of bone density measurements: a method with optimal properties for calibration among several instruments. J Bone Miner Res (1997) 1.73
Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab (1995) 1.69
Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index. Eur J Nutr (2008) 1.51
Despite mandatory fortification of staple foods, vitamin D intakes of Canadian children and adults are inadequate. J Steroid Biochem Mol Biol (2010) 1.42
Peak bone mass from longitudinal data: implications for the prevalence, pathophysiology, and diagnosis of osteoporosis. J Bone Miner Res (2010) 1.37
Use of calcium supplements and the risk of coronary heart disease in 52-62-year-old women: The Kuopio Osteoporosis Risk Factor and Prevention Study. Maturitas (2009) 1.34
Multiple imputation to account for missing data in a survey: estimating the prevalence of osteoporosis. Epidemiology (2002) 1.24
Temporal trends and determinants of longitudinal change in 25-hydroxyvitamin D and parathyroid hormone levels. J Bone Miner Res (2012) 1.18
The role of calcium in health and disease. Am J Obstet Gynecol (1999) 1.05
Does standardized BMD still remove differences between Hologic and GE-Lunar state-of-the-art DXA systems? Osteoporos Int (2009) 1.04
The influence of vitamin D on bone health across the life cycle. J Nutr (2005) 1.00
Calcium and vitamin D intakes in an adult Canadian population. Can J Diet Pract Res (2009) 1.00
Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial. J Clin Endocrinol Metab (1999) 0.98
A review of calcium supplements and cardiovascular disease risk. Adv Nutr (2012) 0.94
Vitamin D therapy in clinical practice. One dose does not fit all. Int J Clin Pract (2007) 0.93
Calcium supplementation, cardiovascular disease and mortality in older women. Pharmacoepidemiol Drug Saf (2010) 0.87
Many adult Canadians are not meeting current calcium recommendations from food and supplement intake. Appl Physiol Nutr Metab (2009) 0.85
Bones and beyond: an update on the role of vitamin D in child and adolescent health in Canada. Appl Physiol Nutr Metab (2007) 0.81
Osteoporosis: preventive strategies. Int J Fertil Womens Med (1998) 0.80
Normative bone mineral density z-scores for Canadians aged 16 to 24 years: the Canadian Multicenter Osteoporosis Study. J Clin Densitom (2010) 0.77
Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet (1995) 7.17
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
Risk of new vertebral fracture in the year following a fracture. JAMA (2001) 6.17
Analysis of 1.9 Mb of contiguous sequence from chromosome 4 of Arabidopsis thaliana. Nature (1998) 5.91
Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int (2009) 5.43
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl J Med (1995) 3.92
Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. CMAJ (2000) 3.77
The glycemic index: methodology and clinical implications. Am J Clin Nutr (1991) 3.24
Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med (1987) 3.13
DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum Genet (1984) 2.92
Current and projected rates of hip fracture in Canada. CMAJ (1997) 2.85
IOF position statement: vitamin D recommendations for older adults. Osteoporos Int (2010) 2.79
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69
Targeted expression of constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide delays endochondral bone formation and rescues mice that lack parathyroid hormone-related peptide. Proc Natl Acad Sci U S A (1997) 2.52
First direct observation of a nearly ideal graphene band structure. Phys Rev Lett (2009) 2.41
Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int (2000) 2.40
The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int (2001) 2.32
Targeted ablation of the 25-hydroxyvitamin D 1alpha -hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci U S A (2001) 2.30
Antidepressant medication use and breast cancer risk. Am J Epidemiol (2000) 2.29
The relationship between proton pump inhibitor use and longitudinal change in bone mineral density: a population-based study [corrected] from the Canadian Multicentre Osteoporosis Study (CaMos). Am J Gastroenterol (2012) 2.24
The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial. Ann Intern Med (1994) 2.08
Extracorporeal photopheresis in the treatment of AIDS-related complex: a pilot study. Ann Intern Med (1990) 2.08
Myosin conformational states determined by single fluorophore polarization. Proc Natl Acad Sci U S A (1998) 2.07
Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J Cell Biol (1994) 2.00
Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate. J Clin Endocrinol Metab (2000) 2.00
Amino-acid sequence of equine renal metallothionein-1B. Proc Natl Acad Sci U S A (1976) 1.99
Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study Group. Osteoporos Int (1999) 1.98
Cancer registration in Ontario: a computer approach. IARC Sci Publ (1991) 1.97
Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry. CMAJ (2000) 1.94
Why multilayer graphene on 4H-SiC(0001[over ]) behaves like a single sheet of graphene. Phys Rev Lett (2008) 1.92
Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling. Proc Natl Acad Sci U S A (2001) 1.88
The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2008) 1.86
Augmented trochanteric bone mineral density after modified physical education classes: a randomized school-based exercise intervention study in prepubescent and early pubescent children. J Pediatr (2000) 1.85
The steroidal aromatase inhibitor exemestane prevents bone loss in ovariectomized rats. Bone (2004) 1.84
Dietary changes favorably affect bone remodeling in older adults. J Am Diet Assoc (1999) 1.84
Nonsteroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol Biomarkers Prev (2001) 1.83
Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiol (1991) 1.78
The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study. Osteoporos Int (2012) 1.76
Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J Am Acad Dermatol (1992) 1.75
Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy. Proc Natl Acad Sci U S A (1983) 1.75
Nucleolar localization of parathyroid hormone-related peptide enhances survival of chondrocytes under conditions that promote apoptotic cell death. Mol Cell Biol (1995) 1.73
Metabolic acidosis in the alcoholic: a pathophysiologic approach. Metabolism (1983) 1.70
Scalable templated growth of graphene nanoribbons on SiC. Nat Nanotechnol (2010) 1.66
Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia. Stroke (2004) 1.66
Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat Res (1988) 1.66
Association of chronic urticaria and angioedema with thyroid autoimmunity. Arch Dermatol (1983) 1.65
Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems. J Am Coll Cardiol (1996) 1.65
The care gap in diagnosis and treatment of women with a fragility fracture. Osteoporos Int (2007) 1.64
Evidence for a humoral mechanism for enhanced osteogenesis after head injury. J Bone Joint Surg Am (1990) 1.64
Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis. J Hepatol (2011) 1.62
Termination of mammalian rDNA replication: polar arrest of replication fork movement by transcription termination factor TTF-I. Cell (1997) 1.61
An epidemiologic study of hip fracture in postmenopausal women. Am J Epidemiol (1982) 1.60
[Specific interference with development and plastid enzyme formation in higher plants by elevated growth temperature]. Z Naturforsch B (1969) 1.60
Comparison of self-reported and physician-reported antidepressant medication use. Ann Epidemiol (1999) 1.60
Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data. Diabetologia (2004) 1.57
Prevalence of IgA-antiendomysial antibody in asymptomatic low bone mineral density. Am J Gastroenterol (2001) 1.54
Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. Int J Cancer (2000) 1.52
The transcription factor SOX9 regulates cell cycle and differentiation genes in chondrocytic CFK2 cells. J Biol Chem (2001) 1.51
Photopheresis for the treatment of cutaneous T cell lymphoma. J Am Acad Dermatol (1990) 1.49
The osteoporosis care gap in men with fragility fractures: the Canadian Multicentre Osteoporosis Study. Osteoporos Int (2007) 1.48
The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int (2003) 1.47
Kinetics of folding of leucine zipper domains. Biochemistry (1995) 1.47
Programmed cell death of chondrocytes and aberrant chondrogenesis in mice homozygous for parathyroid hormone-related peptide gene deletion. Endocrinology (1996) 1.46
Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment after fragility fracture: secondary analyses from two controlled trials. Osteoporos Int (2014) 1.45
The SCARF osteotomy for the correction of hallux valgus deformities. Foot Ankle Int (2002) 1.45
Characterization of tissue and plasma glycosaminoglycans during experimental AA amyloidosis and acute inflammation. Qualitative and quantitative analysis. Lab Invest (1987) 1.44
Osteomalacia in hyp mice is associated with abnormal phex expression and with altered bone matrix protein expression and deposition. Endocrinology (2001) 1.43
Low glycemic index: lente carbohydrates and physiological effects of altered food frequency. Am J Clin Nutr (1994) 1.42
No relationship between carbohydrate intake and effect of acarbose on HbA1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrate. Diabetes Care (1998) 1.42
Acute fulminant hepatitis after treatment with rabeprazole and terbinafine. Arch Intern Med (2001) 1.42